Growth Metrics

Sol-Gel Technologies (SLGL) Common Equity (2016 - 2025)

Sol-Gel Technologies (SLGL) reported Common Equity of $22.8 million for Q4 2025, down 20.93% year-over-year from $28.8 million in Q4 2024, and down 20.93% on a QoQ basis from $28.8 million in Q4 2024.

Sol-Gel Technologies (SLGL) has 10 years of Common Equity data on file, last reported at $22.8 million in Q4 2025.

  • Quarterly Common Equity fell 20.93% year-over-year to $22.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22.8 million (down 20.93% YoY) and the FY2025 annual result came in at $22.8 million, down 20.93% from the prior year.
  • Common Equity eased to $22.8 million in Q4 2025 per SLGL's latest filing, from $28.8 million in the prior quarter.
  • Across five years, Common Equity topped out at $55.6 million in Q4 2021 and bottomed at $22.8 million in Q4 2025.
  • The 5-year median for Common Equity is $38.6 million (2023), against an average of $37.6 million.
  • The widest annual swing landed in 2021, when Common Equity rose 9.33%; it then decreased 25.34% in 2024.
  • Tracing SLGL's Common Equity over 5 years: stood at $55.6 million in 2021, then dropped by 24.07% to $42.2 million in 2022, then declined by 8.45% to $38.6 million in 2023, then declined by 25.34% to $28.8 million in 2024, then fell by 20.93% to $22.8 million in 2025.
  • Per Business Quant, the three latest SLGL Common Equity figures stand at $22.8 million (Q4 2025), $28.8 million (Q4 2024), and $38.6 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -1.42 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 35.63 Mn
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 1.00 Bn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - 13.21 Mn
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 1.08 Bn
10 Sol-Gel Technologies 205.76 Mn 194.73 Mn - 22.81 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 22.81 Mn
Dec 31, 2024 28.85 Mn
Dec 31, 2023 38.64 Mn
Dec 31, 2022 42.21 Mn
Dec 31, 2021 55.59 Mn
Dec 31, 2020 50.85 Mn
Dec 31, 2019 52.47 Mn
Dec 31, 2018 63.91 Mn
Mar 31, 2018 87.04 Mn
Dec 31, 2017 -52.70 Mn
Dec 31, 2016 -31.34 Mn